Clinical Trial Update: Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating combinations or sequential use of therapies with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia (CCR), with unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Versailles Hospital | Conditions: Leukemia, Myeloid, Chronic-Phase | Phase 1, Phase 2 | Status: UNKNOWN